These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26402410)

  • 1. Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    Wang C; Tan L; Wang HF; Yu WJ; Liu Y; Jiang T; Tan MS; Hao XK; Zhang DQ; Yu JT;
    J Alzheimers Dis; 2015; 46(2):491-5. PubMed ID: 26402410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.
    Wang C; Wang HF; Tan MS; Liu Y; Jiang T; Zhang DQ; Tan L; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4343-51. PubMed ID: 26232066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
    Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
    Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.
    Landau SM; Lu M; Joshi AD; Pontecorvo M; Mintun MA; Trojanowski JQ; Shaw LM; Jagust WJ;
    Ann Neurol; 2013 Dec; 74(6):826-36. PubMed ID: 23536396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
    Palmqvist S; Mattsson N; Hansson O;
    Brain; 2016 Apr; 139(Pt 4):1226-36. PubMed ID: 26936941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLD3 in Alzheimer's disease.
    Wang J; Yu JT; Tan L
    Mol Neurobiol; 2015 Apr; 51(2):480-6. PubMed ID: 24935720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.
    Toledo JB; Bjerke M; Da X; Landau SM; Foster NL; Jagust W; Jack C; Weiner M; Davatzikos C; Shaw LM; Trojanowski JQ;
    JAMA Neurol; 2015 May; 72(5):571-81. PubMed ID: 25822737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease.
    Zhu XC; Dai WZ; Ma T
    BMC Med Genet; 2020 Sep; 21(1):181. PubMed ID: 32919460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
    Nackenoff AG; Hohman TJ; Neuner SM; Akers CS; Weitzel NC; Shostak A; Ferguson SM; Mobley B; Bennett DA; Schneider JA; Jefferson AL; Kaczorowski CC; Schrag MS
    PLoS Genet; 2021 Apr; 17(4):e1009406. PubMed ID: 33830999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.
    Lewczuk P; Matzen A; Blennow K; Parnetti L; Molinuevo JL; Eusebi P; Kornhuber J; Morris JC; Fagan AM
    J Alzheimers Dis; 2017; 55(2):813-822. PubMed ID: 27792012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCL2 rs4586 SNP Is Associated with Slower Amyloid-β Deposition and Faster Tau Accumulation of Alzheimer's Disease.
    Gao F; Zhang PF; Gao J; Song J; Chi S;
    J Alzheimers Dis; 2022; 90(4):1647-1657. PubMed ID: 36314210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.
    Alexopoulos P; Guo LH; Kratzer M; Westerteicher C; Kurz A; Perneczky R
    Dement Geriatr Cogn Disord; 2011; 32(3):164-70. PubMed ID: 21997402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
    Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
    Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
    Doecke JD; Rembach A; Villemagne VL; Varghese S; Rainey-Smith S; Sarros S; Evered LA; Fowler CJ; Pertile KK; Rumble RL; Trounson B; Taddei K; Laws SM; Macaulay SL; Bush AI; Ellis KA; Martins R; Ames D; Silbert B; Vanderstichele H; Masters CL; Darby DG; Li QX; Collins S;
    J Alzheimers Dis; 2018; 61(1):169-183. PubMed ID: 29171991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.